Manufacture Business Practice, Clinical Trials, Drug Delivery, Formulation, Small Molecules, Trends & Forecasts

The big reveal: Workhorse + Innovation = more information (Part 1)

A concern raised by the rise in routine MRI screening within the healthcare industry is that the ability to detect abnormalities within the body may currently be running ahead of our understanding of their possible consequences, making it difficult to determine a sound course of action. Here then analytical science is arguably advancing beyond current requirements.

05/07/2015

sponsored by Malvern Panalytical

In other areas the converse is true. Progress is too often hampered by our inability to gather the information needed to make advances. A topical example of this challenge is seen in the pharmaceutical industry where deformulation - the unpicking and rationalization of the performance of a reference labelled drug product - is an essential precursor to the development of a generic equivalent. The FDA has publicly acknowledged the difficulties in replicating complex drugs and has called for advances in analytical instrumentation to help.¹

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.